Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures

Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures

Abstract Background and aim Cardiovascular diseases (CVDs) are globally the leading cause of death and hypertension is a significant risk factor. Treatment with glucagon-like peptide-1 (GLP-1) receptor agonists has been associated with decreases in blood pressure and CVD risk. Our aim was to investi...

Full description

Bibliographic Details
Main Authors: Julie R. Lundgren, Kristine Færch, Daniel R. Witte, Anna E. Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Jens J. Holst, Dorte Vistisen, Marit E. Jørgensen, Signe S. Torekov, Nanna B. Johansen
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Cardiovascular Diabetology
Subjects:
GLP-1
Cardiovascular disease
Central blood pressure
Peripheral blood pressure
Aortic stiffness
Online Access:http://link.springer.com/article/10.1186/s12933-019-0937-7

Internet

http://link.springer.com/article/10.1186/s12933-019-0937-7

Similar Items